BREAST CANCER HOPE
To support and promote research into the causes of breast cancer with the aim of improving the clinical outcome and quality of life of the patients with the disease.To advance education in and understanding of breast cancer and its treatment by providing information to patients with the disease.
Financial health, per its FY2025 accounts
The accounts state that unrestricted funds decreased from £265,042 to £158,923 due to net expenditure of £106,119 against total income of £29,274. The trustees report a reasonable expectation that the charity has adequate resources to continue in operational existence for the foreseeable future. No specific reserves policy target is stated in the document.
What the accounts disclose
Trustees
- PROF KEFAH MOKBELchair
- Prof Amtul Razzaq Carmichael
- Taraneh Azad
Income and spending
| Financial year end | Income | Spending |
|---|---|---|
| 31/03/2025 | £29k | £135k |
| 31/03/2024 | £10k | £54k |
| 31/03/2023 | £2k | £5k |
| 31/03/2022 | £21k | £8k |
| 31/03/2021 | £33k | £39k |
Common questions
Is BREAST CANCER HOPE financially healthy?
Per its FY2025 accounts: The accounts state that unrestricted funds decreased from £265,042 to £158,923 due to net expenditure of £106,119 against total income of £29,274. The trustees report a reasonable expectation that the charity has adequate resources to continue in operational existence for the foreseeable future. No specific reserves policy target is stated in the document. Its FY2025 accounts were independently examined.